Effect of KRAS codon 12 or 13 mutations on survival with trifluridine/tipiracil in pretreated metastatic colorectal cancer: a meta-analysis

BACKGROUND: KRAS gene mutations can predict prognosis and treatment response in patients with metastatic colorectal cancer (mCRC). METHODS: We undertook a meta-analysis of three randomized, placebo-controlled trials (RECOURSE, TERRA and J003) to investigate the impact of KRAS mutations in codons 12...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshino, T., Van Cutsem, E., Li, J., Shen, L., Kim, T.W., Sriuranpong, V., Xuereb, L., Aubel, P., Fougeray, R., Cattan, V., Amellal, N., Ohtsu, A., Mayer, R.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271514/
https://www.ncbi.nlm.nih.gov/pubmed/35688062
http://dx.doi.org/10.1016/j.esmoop.2022.100511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271514/
https://www.ncbi.nlm.nih.gov/pubmed/35688062
http://dx.doi.org/10.1016/j.esmoop.2022.100511

Ejemplares similares